NIH #R01CA304896
Mechanistic Dissection and Modulation of Cytoskeletal Regulation to Overcome Innate Resistance to KRAS Inhibition
Active
- Amount
- $300K–$400K
- Period
- 2025-09-01 → 2030-08-31
- PIs
- 1
Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Victoria Wang
Full Professor(heuristic)
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index22
i10-index33
Publications146
Citations9,874
Grants
4 total · 2 active
NIH #F31DK143749
Investigating the role of NGN3 in Notch signaling repression during pancreatic endocrinogenesis
Active
- Amount
- <$100K
- Period
- 2025-05-01 → 2027-04-30
- PIs
- 1
Awarded at CHILDREN'S HOSPITAL OF LOS ANGELES
NIH #K08CA249744
Mechanistic Determination of KRAS Lung Cancer Regression upon CRAF Suppression
- Amount
- $200K–$300K
- Period
- 2020-06-01 → 2026-03-31
- PIs
- 1
Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Safety and Efficacy in Pediatric Patients with Relapsed/Refractory Classic Hodgkin Lymphoma enrolled on an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin (E4412) (Klinische Pädiatrie)2025-12-01
- New NIH award: Mechanistic Dissection and Modulation of Cytoskeletal Regulation to Overcome Innate Resistance to KRAS Inhibition2025-09-01
- New NIH award: Investigating the role of NGN3 in Notch signaling repression during pancreatic endocrinogenesis2025-05-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-26
Data may not be current